Coaching for Coping in Glioblastoma Patients and Caregivers and Its Association With Compliance to TTFields

Launched by UNIVERSITY HOSPITAL TUEBINGEN · Aug 23, 2023

Keywords

ClinConnect Summary

This clinical trial, called "Coaching for Coping in Glioblastoma Patients and Caregivers," is designed to help patients with glioblastoma and their caregivers better follow their treatment plan using a therapy called TTFields. TTFields is a non-invasive treatment that uses electric fields to disrupt cancer cell growth. The researchers want to see if a psychological video program can improve how well patients stick to this therapy. This trial will take place at multiple centers and is not yet recruiting participants.

To be eligible for this trial, you need to be at least 18 years old and have recently been diagnosed with glioblastoma or a specific type of brain tumor called IDH-mutant Astrocytoma. You should also be planning to start treatment with radiation and chemotherapy shortly. Participants must have access to a computer and the internet to take part in the video program. If you join the trial, you can expect to receive support and coaching to help you manage your treatment better. Overall, this study aims to support patients and caregivers during a challenging time, making it easier for them to follow through with their prescribed therapy.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Ability to understand and give an informed consent, capacity to consent
• • Given informed consent
• • ≥ 18 years of age
• • Patients with newly diagnosed glioblastoma
• • Patients with IDH-mutant Astrocytoma, CNS WHO-Grade 4, newly diagnosed (by biopsy or incomplete tumor resection)
• • Patients eligible for radiochemotherapy with temozolomide and 60 Gy
• • Patients before radiochemotherapy phase or within the first 2 weeks
• • Prescription of TTFields according clinical routine (including but not exclusive to)
• • Access to a computer and internet
• • Absence of medical reasons precluding participation in a supportive intervention
• Exclusion Criteria:
• • Ability to understand and give an informed consent, capacity to consent
• • Given informed consent
• • ≥ 18 years of age
• • Being a family caregiver of a patient with newly diagnosed glioblastoma
• • Access to a computer and internet
• • Absence of medical reasons precluding participation in a supportive intervention